3Ben-Ami H, Nagachandran P, Mendelson A, et al. Drug--induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med, 1999,159(3) :281-284. 被引量：1
4Plosker GL, Figgitt DP, Repaglinide a pharm acoeconom ic review of its use in tyoe 2 diabetes mellitus. Pharm Acoeconomics, 2004,22(6) :389-411. 被引量：1
5Diabetes control and complication trial research (DCCT). The effect of intensive treatment of diabetes on the development and progression of lomg-time complication in insulin-dependent diabetes. N Engl Med, 1993,329(14) :977-986. 被引量：1
6UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patient with type 2 diabetes. Lancet, 1998,352(9131 ) :837-853. 被引量：1
7Humann A, Matthaei S, Rosak C, et al. A randomized clinical trial comparing breakfast , dinner , or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care,2003,26 (6) : 1738-1744. 被引量：1
8Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes[ J ]. Diabetes Care ,2005,28 ( 2 ) : 260 - 265. 被引量：1
9Boland E, Monsod T, Delucia M, et al. Limitations of conventional methods of self-monitoring of blood glucose lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes[ J]. Diabetes Care;2001,24( 11 ) : 1858 - 1862. 被引量：1
10Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring[ J ]. Diabetes Care, 2006,29 ( 12 ) : 2730 - 2732. 被引量：1
